Alaris sells off Instromedix two years after purchase
This article was originally published in Clinica
Executive Summary
Alaris Medical is to sell its Instromedix division to Israel-based Card Guard Scientific Survival for $30 million cash. The sale comes just two years after Alaris bought the cardiac and telemedicine company, paying $55 million.